Product Images Lisinopril

This is a report presenting the incidence and discontinuation rates of adverse effects observed in controlled studies in patients receiving Tiiaaprl hydrochloratiazide. It lists a range of possible side effects and compares their incidence rates between two groups of patients. These include fatigue, asthenia, orthostatic effects, cardiovascular effects, digestive issues, musculoskeletal cramps, headaches, dizziness, coughing, upper respiratory infections, nasal congestion, among others.*

This appears to be a table showing the frequency of certain adverse events for patients receiving high dose and low dose treatment in clinical trials involving Evonts (possibly a drug with registration numbers He1568 and He1595). The adverse events listed include dizziness, hypotension, increased creatinine levels, hyperkalaemia, NPN (non-protein nitrogen) levels increased, and syncope. However, without further information or context, it is difficult to provide a more detailed description or interpretation of the data presented.*

This text appears to be describing dosing guidelines for medication based on the patient's renal function. It lists different levels of impairment and corresponding clearance rates and doses. It also includes a warning for potential allergic reactions during membrane exgosare for dialysis patients. The text suggests adjusting the dosage or dosing interval based on blood pressure response.*

Lisinopril 2.5mg is a medication available in a package of 90 tablets under RX# Master with an expiration date of 00/00/00 and lot number 00000. The NDC number of this medication is 21695-345-90 with an AWP cost of $115.53. The text also includes some illegible characters and symbols.*